Therefore, we evaluated both the evidence and practical challenges to implementing blood-NfL measurement into clinical practice to aid in diagnostic investigations and treatment decisions regarding neuropathy in amyloidosis in the near future. The gene discussed is NEFL; the disease is neuropathy.